Xuedong Liu
Concepts (350)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ubiquitin-Protein Ligases | 10 | 2024 | 192 | 3.070 |
Why?
| | Protein Kinases | 8 | 2024 | 315 | 2.980 |
Why?
| | Transforming Growth Factor beta | 10 | 2016 | 479 | 2.160 |
Why?
| | Keratinocytes | 5 | 2021 | 248 | 1.630 |
Why?
| | Adherens Junctions | 2 | 2021 | 24 | 1.370 |
Why?
| | S-Phase Kinase-Associated Proteins | 6 | 2013 | 20 | 1.330 |
Why?
| | Cell Cycle Proteins | 8 | 2011 | 628 | 1.290 |
Why?
| | Triterpenes | 2 | 2022 | 25 | 1.290 |
Why?
| | Mitochondria | 5 | 2024 | 984 | 1.100 |
Why?
| | Cell Movement | 6 | 2021 | 965 | 1.000 |
Why?
| | Depsipeptides | 3 | 2018 | 15 | 0.980 |
Why?
| | Thiazoles | 4 | 2018 | 135 | 0.950 |
Why?
| | Cell Line | 18 | 2022 | 2882 | 0.910 |
Why?
| | Smad Proteins | 3 | 2010 | 43 | 0.900 |
Why?
| | Ubiquitin | 7 | 2012 | 86 | 0.880 |
Why?
| | Vesiculovirus | 1 | 2024 | 17 | 0.840 |
Why?
| | Carbanilides | 1 | 2024 | 4 | 0.830 |
Why?
| | Signal Transduction | 12 | 2020 | 5226 | 0.820 |
Why?
| | ADAM17 Protein | 2 | 2020 | 42 | 0.780 |
Why?
| | Histone Deacetylase Inhibitors | 3 | 2022 | 220 | 0.770 |
Why?
| | Cannabidiol | 2 | 2022 | 136 | 0.750 |
Why?
| | Enhancer Elements, Genetic | 2 | 2018 | 192 | 0.740 |
Why?
| | Spindle Apparatus | 4 | 2012 | 105 | 0.730 |
Why?
| | Ubiquitination | 5 | 2014 | 118 | 0.720 |
Why?
| | Oleanolic Acid | 1 | 2022 | 9 | 0.720 |
Why?
| | Ubiquitin-Activating Enzymes | 2 | 2012 | 20 | 0.720 |
Why?
| | CDC2-CDC28 Kinases | 4 | 2013 | 17 | 0.720 |
Why?
| | ADAM Proteins | 2 | 2015 | 63 | 0.710 |
Why?
| | alpha Catenin | 2 | 2020 | 11 | 0.700 |
Why?
| | Protein Binding | 11 | 2019 | 2273 | 0.650 |
Why?
| | Mitosis | 2 | 2012 | 200 | 0.630 |
Why?
| | Gene Editing | 1 | 2020 | 93 | 0.610 |
Why?
| | Exosomes | 1 | 2020 | 104 | 0.610 |
Why?
| | Tripterygium | 1 | 2019 | 1 | 0.600 |
Why?
| | Gene Transfer Techniques | 1 | 2020 | 185 | 0.590 |
Why?
| | Epithelial Cells | 6 | 2020 | 1125 | 0.590 |
Why?
| | Wound Healing | 3 | 2021 | 351 | 0.580 |
Why?
| | HEK293 Cells | 5 | 2024 | 744 | 0.580 |
Why?
| | Smad4 Protein | 3 | 2010 | 34 | 0.560 |
Why?
| | Membrane Transport Proteins | 2 | 2019 | 154 | 0.560 |
Why?
| | Amino Acid Sequence | 11 | 2014 | 2155 | 0.550 |
Why?
| | Transcription, Genetic | 5 | 2008 | 1496 | 0.550 |
Why?
| | Cell Nucleus | 5 | 2021 | 618 | 0.550 |
Why?
| | Genome | 3 | 2018 | 306 | 0.540 |
Why?
| | HeLa Cells | 5 | 2020 | 650 | 0.530 |
Why?
| | Histone Code | 1 | 2018 | 38 | 0.530 |
Why?
| | Tumor Suppressor Proteins | 3 | 2005 | 321 | 0.530 |
Why?
| | Ligands | 3 | 2016 | 673 | 0.530 |
Why?
| | Electron Transport Complex III | 1 | 2017 | 18 | 0.530 |
Why?
| | Electron Transport Complex II | 1 | 2017 | 28 | 0.520 |
Why?
| | Mitochondrial Proton-Translocating ATPases | 1 | 2017 | 23 | 0.520 |
Why?
| | Biosensing Techniques | 2 | 2019 | 139 | 0.510 |
Why?
| | Molecular Sequence Data | 12 | 2013 | 2930 | 0.510 |
Why?
| | Receptors, Cell Surface | 1 | 2019 | 377 | 0.500 |
Why?
| | Niacinamide | 1 | 2017 | 86 | 0.500 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2015 | 173 | 0.490 |
Why?
| | Phenylurea Compounds | 1 | 2017 | 112 | 0.490 |
Why?
| | Immunoblotting | 4 | 2012 | 300 | 0.490 |
Why?
| | Software | 3 | 2013 | 690 | 0.480 |
Why?
| | Drug Screening Assays, Antitumor | 3 | 2013 | 191 | 0.470 |
Why?
| | Culture Media, Conditioned | 1 | 2016 | 111 | 0.460 |
Why?
| | Cell Line, Tumor | 10 | 2024 | 3540 | 0.450 |
Why?
| | Fluorescence Resonance Energy Transfer | 2 | 2019 | 178 | 0.430 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 6 | 2013 | 66 | 0.430 |
Why?
| | Mitochondrial Dynamics | 1 | 2014 | 40 | 0.420 |
Why?
| | Phosphorylation | 7 | 2020 | 1732 | 0.420 |
Why?
| | Animals | 27 | 2024 | 38058 | 0.420 |
Why?
| | Smad2 Protein | 2 | 2014 | 37 | 0.400 |
Why?
| | Enzyme Activation | 5 | 2015 | 766 | 0.390 |
Why?
| | Kinetochores | 3 | 2012 | 52 | 0.390 |
Why?
| | F-Box Proteins | 1 | 2013 | 23 | 0.380 |
Why?
| | G1 Phase | 2 | 2010 | 66 | 0.370 |
Why?
| | RNA, Small Interfering | 6 | 2020 | 635 | 0.370 |
Why?
| | Viral Envelope Proteins | 2 | 2024 | 98 | 0.350 |
Why?
| | Mice | 15 | 2024 | 18339 | 0.350 |
Why?
| | Disulfides | 1 | 2012 | 96 | 0.350 |
Why?
| | Antineoplastic Agents | 2 | 2022 | 2194 | 0.350 |
Why?
| | Humans | 41 | 2024 | 144759 | 0.340 |
Why?
| | High-Throughput Screening Assays | 1 | 2013 | 175 | 0.340 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2016 | 780 | 0.320 |
Why?
| | Membrane Glycoproteins | 2 | 2024 | 496 | 0.310 |
Why?
| | Smad3 Protein | 2 | 2014 | 43 | 0.300 |
Why?
| | Protein-Tyrosine Kinases | 5 | 2011 | 433 | 0.300 |
Why?
| | Myogenic Regulatory Factors | 2 | 2006 | 45 | 0.300 |
Why?
| | Oncogene Proteins v-erbA | 1 | 2009 | 1 | 0.290 |
Why?
| | Ubiquitin-Conjugating Enzymes | 2 | 2006 | 17 | 0.290 |
Why?
| | ErbB Receptors | 3 | 2021 | 627 | 0.290 |
Why?
| | SUMO-1 Protein | 2 | 2006 | 22 | 0.290 |
Why?
| | Cyclin E | 2 | 2005 | 23 | 0.290 |
Why?
| | Peptides | 2 | 2013 | 995 | 0.280 |
Why?
| | Enzyme Inhibitors | 1 | 2012 | 824 | 0.280 |
Why?
| | Transforming Growth Factor alpha | 2 | 2020 | 56 | 0.270 |
Why?
| | Parkinson Disease | 1 | 2014 | 600 | 0.270 |
Why?
| | Ubiquitin-Protein Ligase Complexes | 2 | 2004 | 8 | 0.270 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2008 | 142 | 0.270 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 4 | 2012 | 331 | 0.260 |
Why?
| | Regulatory Elements, Transcriptional | 1 | 2007 | 19 | 0.260 |
Why?
| | Sequence Alignment | 3 | 2014 | 366 | 0.260 |
Why?
| | Protein Inhibitors of Activated STAT | 1 | 2006 | 6 | 0.240 |
Why?
| | MADS Domain Proteins | 1 | 2006 | 4 | 0.240 |
Why?
| | Mutation | 8 | 2013 | 4089 | 0.230 |
Why?
| | Myoblasts | 1 | 2006 | 84 | 0.230 |
Why?
| | Mammals | 1 | 2007 | 293 | 0.230 |
Why?
| | Green Fluorescent Proteins | 2 | 2020 | 405 | 0.230 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2005 | 112 | 0.220 |
Why?
| | Microscopy, Fluorescence | 2 | 2019 | 416 | 0.220 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2006 | 214 | 0.210 |
Why?
| | Genome, Human | 1 | 2006 | 422 | 0.210 |
Why?
| | Ligases | 1 | 2004 | 37 | 0.210 |
Why?
| | Computational Biology | 2 | 2007 | 680 | 0.210 |
Why?
| | Cell Cycle | 2 | 2021 | 596 | 0.200 |
Why?
| | Transcriptional Activation | 1 | 2006 | 383 | 0.200 |
Why?
| | Down-Regulation | 1 | 2006 | 627 | 0.200 |
Why?
| | Recombinant Fusion Proteins | 2 | 2021 | 675 | 0.200 |
Why?
| | Models, Molecular | 5 | 2013 | 1618 | 0.200 |
Why?
| | Albumins | 1 | 2024 | 118 | 0.200 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2003 | 76 | 0.190 |
Why?
| | Recombinant Proteins | 4 | 2010 | 1370 | 0.190 |
Why?
| | Amino Acid Motifs | 4 | 2011 | 224 | 0.190 |
Why?
| | Epidermal Growth Factor | 2 | 2020 | 171 | 0.190 |
Why?
| | Telomeric Repeat Binding Protein 1 | 2 | 2013 | 6 | 0.190 |
Why?
| | Binding Sites | 4 | 2016 | 1329 | 0.190 |
Why?
| | Glycoproteins | 1 | 2024 | 355 | 0.180 |
Why?
| | RNA, Messenger | 4 | 2022 | 2832 | 0.180 |
Why?
| | Mass Spectrometry | 1 | 2005 | 750 | 0.180 |
Why?
| | Substrate Specificity | 3 | 2009 | 388 | 0.180 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2018 | 2027 | 0.180 |
Why?
| | Receptors, Transforming Growth Factor beta | 2 | 2014 | 57 | 0.170 |
Why?
| | Extracellular Vesicles | 1 | 2024 | 171 | 0.170 |
Why?
| | Viral Proteins | 1 | 2024 | 355 | 0.170 |
Why?
| | Acetylation | 2 | 2022 | 252 | 0.170 |
Why?
| | Transfection | 3 | 2012 | 940 | 0.170 |
Why?
| | Cell Proliferation | 4 | 2020 | 2496 | 0.170 |
Why?
| | Proto-Oncogene Proteins | 1 | 2004 | 623 | 0.170 |
Why?
| | Caspase 9 | 1 | 2020 | 55 | 0.170 |
Why?
| | Argonaute Proteins | 1 | 2020 | 31 | 0.170 |
Why?
| | Photochemical Processes | 1 | 2021 | 108 | 0.160 |
Why?
| | Metalloproteases | 1 | 2020 | 42 | 0.160 |
Why?
| | RAW 264.7 Cells | 1 | 2020 | 50 | 0.160 |
Why?
| | Blotting, Western | 2 | 2016 | 1187 | 0.160 |
Why?
| | Drug Delivery Systems | 1 | 2024 | 380 | 0.160 |
Why?
| | Protein Structure, Tertiary | 3 | 2010 | 862 | 0.160 |
Why?
| | Histone Deacetylases | 2 | 2022 | 210 | 0.160 |
Why?
| | Paracrine Communication | 1 | 2020 | 67 | 0.160 |
Why?
| | Mink | 3 | 2004 | 12 | 0.160 |
Why?
| | Sequence Homology, Amino Acid | 3 | 2006 | 396 | 0.160 |
Why?
| | Integrases | 1 | 2020 | 122 | 0.160 |
Why?
| | Cell Death | 1 | 2021 | 383 | 0.150 |
Why?
| | Cannabinoids | 1 | 2022 | 182 | 0.150 |
Why?
| | Apoptosis | 2 | 2022 | 2430 | 0.150 |
Why?
| | Protein Conformation | 3 | 2009 | 946 | 0.150 |
Why?
| | Pentacyclic Triterpenes | 1 | 2019 | 12 | 0.150 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2003 | 419 | 0.150 |
Why?
| | Base Sequence | 3 | 2014 | 2190 | 0.150 |
Why?
| | Hydrazones | 1 | 2019 | 26 | 0.150 |
Why?
| | Cell Culture Techniques | 2 | 2016 | 375 | 0.150 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2019 | 75 | 0.150 |
Why?
| | Cells, Cultured | 3 | 2017 | 4154 | 0.140 |
Why?
| | HSP90 Heat-Shock Proteins | 1 | 2019 | 47 | 0.140 |
Why?
| | Neoplasms | 4 | 2022 | 2875 | 0.140 |
Why?
| | Enzymes | 1 | 2019 | 65 | 0.140 |
Why?
| | Polymerization | 1 | 2019 | 130 | 0.140 |
Why?
| | Cytostatic Agents | 1 | 2018 | 6 | 0.140 |
Why?
| | Lymphoma, B-Cell | 1 | 2019 | 132 | 0.140 |
Why?
| | RNA Interference | 3 | 2016 | 476 | 0.140 |
Why?
| | Cell Line, Transformed | 1 | 2018 | 140 | 0.130 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1253 | 0.130 |
Why?
| | Models, Biological | 3 | 2016 | 1821 | 0.130 |
Why?
| | Chromatin Immunoprecipitation | 2 | 2008 | 139 | 0.130 |
Why?
| | Oncogenes | 1 | 2018 | 119 | 0.130 |
Why?
| | Catalysis | 2 | 2010 | 322 | 0.130 |
Why?
| | Electron Transport | 1 | 2017 | 118 | 0.130 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2019 | 264 | 0.130 |
Why?
| | Genes, Reporter | 2 | 2008 | 275 | 0.130 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2019 | 199 | 0.120 |
Why?
| | DNA-Binding Proteins | 1 | 2004 | 1499 | 0.120 |
Why?
| | Vacuoles | 1 | 2016 | 38 | 0.120 |
Why?
| | Histones | 2 | 2022 | 669 | 0.120 |
Why?
| | Microtubules | 1 | 2019 | 286 | 0.120 |
Why?
| | Reproducibility of Results | 1 | 2024 | 3409 | 0.120 |
Why?
| | Glycosylphosphatidylinositols | 1 | 2015 | 12 | 0.110 |
Why?
| | Haploidy | 1 | 2015 | 28 | 0.110 |
Why?
| | Cyclin-Dependent Kinase 2 | 2 | 2005 | 36 | 0.110 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2011 | 459 | 0.110 |
Why?
| | Valinomycin | 1 | 2014 | 3 | 0.110 |
Why?
| | Transcription Factors | 3 | 2008 | 1741 | 0.110 |
Why?
| | Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2014 | 4 | 0.110 |
Why?
| | RNA-Binding Proteins | 2 | 2016 | 462 | 0.110 |
Why?
| | RNA Stability | 1 | 2016 | 119 | 0.110 |
Why?
| | Virulence Factors | 1 | 2016 | 172 | 0.110 |
Why?
| | Salmonella typhimurium | 1 | 2016 | 190 | 0.110 |
Why?
| | Glutathione Transferase | 2 | 2005 | 100 | 0.110 |
Why?
| | Cytoprotection | 1 | 2014 | 55 | 0.110 |
Why?
| | Anaphase-Promoting Complex-Cyclosome | 2 | 2004 | 12 | 0.110 |
Why?
| | RNA Polymerase II | 1 | 2018 | 351 | 0.110 |
Why?
| | Algorithms | 2 | 2016 | 1837 | 0.100 |
Why?
| | Cell Differentiation | 3 | 2007 | 2050 | 0.100 |
Why?
| | Structure-Activity Relationship | 2 | 2013 | 570 | 0.100 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 266 | 0.100 |
Why?
| | MAP Kinase Kinase 1 | 1 | 2014 | 71 | 0.100 |
Why?
| | Arginine | 2 | 2005 | 262 | 0.100 |
Why?
| | Rabbits | 2 | 2005 | 648 | 0.100 |
Why?
| | Cytoskeleton | 1 | 2015 | 195 | 0.100 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2019 | 881 | 0.100 |
Why?
| | para-Aminobenzoates | 1 | 2013 | 8 | 0.100 |
Why?
| | T-Box Domain Proteins | 1 | 2014 | 106 | 0.100 |
Why?
| | Lysine | 2 | 2006 | 302 | 0.100 |
Why?
| | Hydroquinones | 1 | 2013 | 29 | 0.100 |
Why?
| | Repressor Proteins | 2 | 2008 | 437 | 0.100 |
Why?
| | Promoter Regions, Genetic | 1 | 2018 | 1257 | 0.100 |
Why?
| | Benzoates | 1 | 2013 | 50 | 0.100 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2011 | 121 | 0.100 |
Why?
| | Molecular Structure | 2 | 2012 | 499 | 0.100 |
Why?
| | MAP Kinase Signaling System | 1 | 2015 | 310 | 0.100 |
Why?
| | Endoplasmic Reticulum | 1 | 2015 | 266 | 0.100 |
Why?
| | Protein Interaction Maps | 1 | 2013 | 51 | 0.100 |
Why?
| | Genetic Vectors | 2 | 2005 | 337 | 0.100 |
Why?
| | Gene Expression Regulation | 2 | 2016 | 2608 | 0.100 |
Why?
| | Time Factors | 4 | 2016 | 7173 | 0.090 |
Why?
| | Proteins | 1 | 2019 | 1021 | 0.090 |
Why?
| | Yeasts | 1 | 2012 | 52 | 0.090 |
Why?
| | Adenosine Triphosphate | 1 | 2014 | 498 | 0.090 |
Why?
| | Liver | 1 | 2020 | 1887 | 0.090 |
Why?
| | Drug Design | 1 | 2013 | 173 | 0.090 |
Why?
| | Carrier Proteins | 2 | 2007 | 737 | 0.090 |
Why?
| | Cytokinesis | 1 | 2012 | 50 | 0.090 |
Why?
| | M Phase Cell Cycle Checkpoints | 1 | 2011 | 24 | 0.090 |
Why?
| | Cell Survival | 2 | 2016 | 1098 | 0.080 |
Why?
| | Immunoprecipitation | 2 | 2016 | 151 | 0.080 |
Why?
| | Proteolysis | 1 | 2012 | 173 | 0.080 |
Why?
| | Small Molecule Libraries | 1 | 2012 | 111 | 0.080 |
Why?
| | Cell Extracts | 1 | 2010 | 21 | 0.080 |
Why?
| | Rosaniline Dyes | 1 | 2010 | 15 | 0.080 |
Why?
| | Cell Fractionation | 1 | 2010 | 52 | 0.080 |
Why?
| | Cell Division | 1 | 2011 | 766 | 0.080 |
Why?
| | Bacterial Proteins | 1 | 2016 | 955 | 0.080 |
Why?
| | Molecular Imaging | 1 | 2010 | 55 | 0.080 |
Why?
| | Staining and Labeling | 1 | 2010 | 151 | 0.070 |
Why?
| | Adenine | 1 | 2012 | 339 | 0.070 |
Why?
| | Glucose | 1 | 2014 | 1047 | 0.070 |
Why?
| | Nuclear Proteins | 2 | 2015 | 748 | 0.070 |
Why?
| | Cytoplasm | 1 | 2010 | 269 | 0.070 |
Why?
| | Fluorescent Antibody Technique | 1 | 2010 | 370 | 0.070 |
Why?
| | Mad2 Proteins | 1 | 2008 | 5 | 0.070 |
Why?
| | Erythroblasts | 1 | 2009 | 19 | 0.070 |
Why?
| | Statistics as Topic | 1 | 2010 | 284 | 0.070 |
Why?
| | Culture Media | 1 | 2009 | 161 | 0.070 |
Why?
| | ADAMTS5 Protein | 1 | 2008 | 4 | 0.070 |
Why?
| | Energy Metabolism | 1 | 2014 | 935 | 0.070 |
Why?
| | Macrophages | 1 | 2016 | 1511 | 0.070 |
Why?
| | Dimerization | 1 | 2008 | 194 | 0.070 |
Why?
| | Rats | 2 | 2007 | 5597 | 0.070 |
Why?
| | RNA-Induced Silencing Complex | 1 | 2007 | 7 | 0.070 |
Why?
| | RNA, Helminth | 1 | 2007 | 18 | 0.070 |
Why?
| | Body Patterning | 1 | 2008 | 138 | 0.070 |
Why?
| | Mice, Knockout | 1 | 2015 | 3121 | 0.070 |
Why?
| | Nocodazole | 1 | 2007 | 17 | 0.070 |
Why?
| | Smad1 Protein | 1 | 2007 | 17 | 0.070 |
Why?
| | Base Pairing | 1 | 2007 | 65 | 0.060 |
Why?
| | Calcium-Binding Proteins | 1 | 2008 | 219 | 0.060 |
Why?
| | Mutagenesis | 1 | 2008 | 192 | 0.060 |
Why?
| | Muscles | 1 | 2008 | 333 | 0.060 |
Why?
| | Luciferases | 1 | 2007 | 152 | 0.060 |
Why?
| | Drosophila | 1 | 2008 | 166 | 0.060 |
Why?
| | Exons | 1 | 2008 | 358 | 0.060 |
Why?
| | Conserved Sequence | 1 | 2007 | 245 | 0.060 |
Why?
| | Muscle Development | 1 | 2007 | 116 | 0.060 |
Why?
| | Myogenin | 1 | 2006 | 15 | 0.060 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2006 | 96 | 0.060 |
Why?
| | MyoD Protein | 1 | 2006 | 31 | 0.060 |
Why?
| | Membrane Fusion | 1 | 2006 | 40 | 0.060 |
Why?
| | Consensus Sequence | 1 | 2006 | 74 | 0.060 |
Why?
| | MEF2 Transcription Factors | 1 | 2006 | 51 | 0.060 |
Why?
| | Species Specificity | 1 | 2007 | 574 | 0.060 |
Why?
| | Reticulocytes | 1 | 2005 | 17 | 0.060 |
Why?
| | Threonine | 1 | 2005 | 46 | 0.060 |
Why?
| | Peptide Mapping | 1 | 2005 | 63 | 0.060 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2007 | 210 | 0.060 |
Why?
| | GTPase-Activating Proteins | 1 | 2005 | 82 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 983 | 0.060 |
Why?
| | Molecular Weight | 1 | 2005 | 327 | 0.060 |
Why?
| | Selection, Genetic | 1 | 2007 | 256 | 0.060 |
Why?
| | DNA, Complementary | 1 | 2005 | 276 | 0.050 |
Why?
| | Insecta | 1 | 2005 | 74 | 0.050 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2005 | 381 | 0.050 |
Why?
| | Xenopus | 1 | 2004 | 89 | 0.050 |
Why?
| | Aspartic Acid | 1 | 2004 | 88 | 0.050 |
Why?
| | Phosphates | 1 | 2005 | 180 | 0.050 |
Why?
| | User-Computer Interface | 1 | 2005 | 164 | 0.050 |
Why?
| | Caenorhabditis elegans | 1 | 2007 | 337 | 0.050 |
Why?
| | Staphylococcal Protein A | 1 | 2003 | 13 | 0.050 |
Why?
| | S Phase | 1 | 2004 | 80 | 0.050 |
Why?
| | Retroviridae | 1 | 2004 | 101 | 0.050 |
Why?
| | Genes, Tumor Suppressor | 1 | 2004 | 83 | 0.050 |
Why?
| | Endopeptidases | 1 | 2003 | 82 | 0.050 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2003 | 143 | 0.050 |
Why?
| | Static Electricity | 1 | 2003 | 113 | 0.050 |
Why?
| | Gene Deletion | 1 | 2004 | 389 | 0.050 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2004 | 123 | 0.050 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2004 | 269 | 0.050 |
Why?
| | Cloning, Molecular | 1 | 2003 | 540 | 0.050 |
Why?
| | Histone Deacetylase 1 | 1 | 2022 | 23 | 0.050 |
Why?
| | 3' Untranslated Regions | 2 | 2016 | 152 | 0.040 |
Why?
| | Oligopeptides | 1 | 2003 | 269 | 0.040 |
Why?
| | Epitopes | 1 | 2003 | 485 | 0.040 |
Why?
| | MicroRNAs | 1 | 2007 | 701 | 0.040 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2022 | 190 | 0.040 |
Why?
| | Escherichia coli | 1 | 2005 | 854 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 1985 | 0.040 |
Why?
| | Internet | 1 | 2005 | 699 | 0.040 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2003 | 427 | 0.040 |
Why?
| | Cholesterol | 1 | 2022 | 406 | 0.040 |
Why?
| | DNA | 1 | 2007 | 1463 | 0.040 |
Why?
| | Sequence Analysis, RNA | 2 | 2016 | 442 | 0.040 |
Why?
| | Gene Knock-In Techniques | 1 | 2019 | 61 | 0.040 |
Why?
| | Ions | 1 | 2019 | 71 | 0.040 |
Why?
| | Drug Synergism | 1 | 2019 | 357 | 0.030 |
Why?
| | Homeostasis | 1 | 2022 | 640 | 0.030 |
Why?
| | Computer Simulation | 2 | 2016 | 1025 | 0.030 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 154 | 0.030 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2019 | 202 | 0.030 |
Why?
| | Calcium | 1 | 2022 | 1183 | 0.030 |
Why?
| | Optical Imaging | 1 | 2016 | 64 | 0.030 |
Why?
| | Microbial Viability | 1 | 2016 | 90 | 0.030 |
Why?
| | Female | 2 | 2021 | 78271 | 0.030 |
Why?
| | CD59 Antigens | 1 | 2015 | 20 | 0.030 |
Why?
| | Phosphotransferases | 1 | 2015 | 27 | 0.030 |
Why?
| | Prions | 1 | 2015 | 50 | 0.030 |
Why?
| | Cell Adhesion | 1 | 2016 | 455 | 0.030 |
Why?
| | Protein Transport | 1 | 2015 | 441 | 0.020 |
Why?
| | Molecular Chaperones | 1 | 2015 | 200 | 0.020 |
Why?
| | Single-Cell Analysis | 1 | 2016 | 358 | 0.020 |
Why?
| | Kinetics | 1 | 2016 | 1627 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2016 | 549 | 0.020 |
Why?
| | G2 Phase | 1 | 2011 | 39 | 0.020 |
Why?
| | Chromosome Segregation | 1 | 2011 | 46 | 0.020 |
Why?
| | Lung | 1 | 2004 | 4109 | 0.020 |
Why?
| | Quinolines | 1 | 2011 | 193 | 0.020 |
Why?
| | Transcriptome | 1 | 2016 | 1045 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2016 | 1406 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2015 | 1166 | 0.020 |
Why?
| | Breast Neoplasms | 1 | 2021 | 2452 | 0.020 |
Why?
| | Solutions | 1 | 2008 | 166 | 0.020 |
Why?
| | Monte Carlo Method | 1 | 2008 | 155 | 0.020 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2007 | 32 | 0.020 |
Why?
| | RNA Caps | 1 | 2007 | 33 | 0.020 |
Why?
| | Endoribonucleases | 1 | 2007 | 80 | 0.020 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2008 | 630 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 2007 | 458 | 0.010 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2007 | 905 | 0.010 |
Why?
|
|
Liu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|